| Kimberly A Mackey, MD | |
|
2211 Lomas Blvd Ne, Albuquerque, NM 87106 | |
| (505) 272-2111 | |
| (505) 272-8060 |
| Full Name | Kimberly A Mackey |
|---|---|
| Gender | Female |
| Speciality | Neurosurgery |
| Experience | 16 Years |
| Location | 2211 Lomas Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1952533739 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD2016-0569 (New Mexico) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| South Georgia Medical Center | Valdosta, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sgmc Physician Network Inc | 4082036843 | 107 |
News Archive
The Centers for Disease Control and Prevention estimate that between 1.6 and 3.8 million concussions occur each year in the US. In addition, research indicates that nearly a quarter of annual traumatic brain injuries among children are sustained during high-contact/collision recreational activities or sports.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced positive top-line results from Category 1 abuse-deterrent studies for Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A federal judge intervened in the case of a 10-year-old girl with cystic fibrosis who needs a lung transplant, ordering HHS Secretary Kathleen Sebelius to provide an exception and place the girl on the adult lung transplant list.
For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.
› Verified 7 days ago
| Entity Name | Sgmc Physician Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417597170 PECOS PAC ID: 4082036843 Enrollment ID: O20201015000629 |
News Archive
The Centers for Disease Control and Prevention estimate that between 1.6 and 3.8 million concussions occur each year in the US. In addition, research indicates that nearly a quarter of annual traumatic brain injuries among children are sustained during high-contact/collision recreational activities or sports.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced positive top-line results from Category 1 abuse-deterrent studies for Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A federal judge intervened in the case of a 10-year-old girl with cystic fibrosis who needs a lung transplant, ordering HHS Secretary Kathleen Sebelius to provide an exception and place the girl on the adult lung transplant list.
For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kimberly A Mackey, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106-2719 Ph: (505) 272-2111 | Kimberly A Mackey, MD 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Ph: (505) 272-2111 |
News Archive
The Centers for Disease Control and Prevention estimate that between 1.6 and 3.8 million concussions occur each year in the US. In addition, research indicates that nearly a quarter of annual traumatic brain injuries among children are sustained during high-contact/collision recreational activities or sports.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T-cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today the receipt of the latest milestone payment of EUR 1 million from the Ovasave collaboration option, development and license agreement from Trizell (Trizell Holding SA).
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced positive top-line results from Category 1 abuse-deterrent studies for Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A federal judge intervened in the case of a 10-year-old girl with cystic fibrosis who needs a lung transplant, ordering HHS Secretary Kathleen Sebelius to provide an exception and place the girl on the adult lung transplant list.
For patients taking proton pump inhibitors to treat gastroesophageal disease (GERD) or other acid-related conditions, new research puts safety concerns to rest.
› Verified 7 days ago
Dr. Gerald Nathan Gold, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1509 Harvard Ct Ne, Albuquerque, NM 87106 Phone: 505-255-0555 | |
Mehrnoush Gorjian, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: Department Of Neurosurgery 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-4280 | |
Sheila Rose Eshraghi, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1 University Of New Mexico, Msc10 5615, Albuquerque, NM 87131 Phone: 505-272-3401 | |
Daniel Shibuya, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne, Ste 401, Albuquerque, NM 87102 Phone: 505-727-5910 Fax: 505-727-5939 | |
Dr. James Andrew Botros, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-3401 | |
Paul Turner, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 5-north University Hospital, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-3160 | |
Dr. Chad Douglas Cole, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-0621 |